Aegis CEO Basile – ‘Medication adherence is our core product offering, competency’ – NashvillePost Written by: Alex Curtis | Posted Jul 16, 2018 via ‘Medication adherence is our core product offering, competency’ | Nashville Post Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window) Related Tags: Aegis Sciences Corporation health data healthcare healthtech medication NashvillePost Further Reading: CereCore Names New Chief Operating Officer, Elevates VP of Business Development to New Role of Chief Commercial Officer Written by: Alex Curtis | Posted Jul 19, 2024 Read More › S3 Acquires California-based iGlobal Asset Management Written by: Alex Curtis | Posted Jul 18, 2024 Read More › LBMC Expands Consulting and Business Intelligence Practice with Leading Experts in Healthcare AI and Data Strategy Written by: Alex Curtis | Posted Jul 17, 2024 Read More ›